QA: ACHILLION PHARMACEUTICALS INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001070336_2018_ACHILLION_PHARMACEUTICALS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001070336')"}

Graph

Absolute values for 0001070336, ACHILLION PHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 303,938,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,816,000
3 remainder_Assets 30,859,000
4 LiabilitiesCurrent 12,884,000
5 LiabilitiesNoncurrent 131,000
6 remainder_Liabilities 83,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,524,000
9 ResearchAndDevelopmentExpense 65,052,000
10 remainder_Expenses 50,000
11 remainder_Revenues 0
12 remainder_NetIncome 4,390,000
13 remainder_ComprehensiveNetIncome -540,000
  yvar yval
0 Assets 337,613,000
1 Liabilities 13,098,000
2 Expenses 89,626,000
3 Revenues 0
4 StockholdersEquity 324,515,000
5 NetIncome -85,236,000
6 ComprehensiveNetIncome -85,506,000
7 BaseVar 222,633,500
8 EconomicCapitalRatio 2.70

Edgar->Model Mapping

Feature Distribution

Change over Time